Ergometer Training in Patients With OSA
Launched by INSTITUT FÜR PNEUMOLOGIE HAGEN AMBROCK EV · Oct 20, 2011
Trial Information
Current as of April 27, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Suspected OSA
- • 2. Capable of giving consent
- Exclusion Criteria:
- • 1. Symptomatic cardial infarction
- • 2. Decompensated cardiac insufficiency
- • 3. Hemodynamically effective cardiac arrhythmias
- • 4. Hemodynamically significant Vitia (heart disease)
- • 5. Insufficiently regulated arterial hypertension
- • 6. Global respiratory insufficiency
- • 7. Significant partial insufficiency (PAO2 \<50mmHg or SaO2 \< 80% at rest)
- • 8. State after decompensation of Cor Pulmonale
- • 9. Right ventricular strain at pulmonary hypertension at rest (pulmonary arterial pressure \> 20 mmHg)
- • 10. Severe osteoporosis
- • 11. Higher degree of lung functional restriction: FEV1 \<50% oder \>60% of nominal value after bronchospasmolysis
- • 12. Working performance on ergometer \< 50%
- • 13. Unstable bronchial asthma
- • 14. Exacerbated COPD
- • 15. Heavily overweight (BMI \>40 or weight \>140kg)
About Institut Für Pneumologie Hagen Ambrock Ev
The Institut für Pneumologie Hagen Ambrock e.V. is a leading clinical research organization focused on advancing the understanding and treatment of respiratory diseases. With a commitment to innovative research and patient-centered care, the institute collaborates with healthcare professionals, academic institutions, and industry partners to conduct rigorous clinical trials. Its multidisciplinary team employs state-of-the-art methodologies to develop new therapies and improve existing treatment protocols, ultimately aiming to enhance patient outcomes in the field of pulmonology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hagen, Nrw, Germany
Patients applied
Trial Officials
Karl Heinz Ruehle, Prof
Principal Investigator
Institut für Pneumologie Hagen Ambrock eV
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials